Form D · Pharmaceuticals

XTuit Pharmaceuticals, Inc.

Waltham, MA · CIK 0001598271

Offering snapshot reported Sep 2, 2016 · SEC filing

Reported sold: $22M
Investors reported: 10
Minimum accepted: $0
First sale: Nov 20, 2014

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$12,008,500 → $22,016,999
Reported investors9 → 10

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 2, 2016	Amendment	$22,016,999	$10,008,499vs Jun 11, 2015	10	SEC filing
Jun 11, 2015	Amendment	$12,008,500	$8,008,500vs Dec 5, 2014	9	SEC filing
Dec 5, 2014	Initial	$4,000,000	No comparison	3	SEC filing
Jan 31, 2014	Initial	$1,508,513	No comparison	2	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-229519

Source: Form D, filed Sep 2, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Alan Crane	Director
Edward Freedman	Executive
Rakesh Jain	Director
Robert Langer	Director
David Mott	Director
Garry Nicholson	Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

35 Gatehouse Drive Suite A1
Waltham, MA, 02451